Literature DB >> 21159636

Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects.

Manishkumar R Patel1, Ya-Fang Chang, Ian Y Chen, Michael H Bachmann, Xinrui Yan, Christopher H Contag, Sanjiv S Gambhir.   

Abstract

Adoptive immunotherapy is evolving to assume an increasing role in treating cancer. Most imaging studies in adoptive immunotherapy to date have focused primarily on locating tumor-specific T cells rather than understanding their effector functions. In this study, we report the development of a noninvasive imaging strategy to monitor T-cell activation in living subjects by linking a reporter gene to the Granzyme B promoter (pGB), whose transcriptional activity is known to increase during T-cell activation. Because pGB is relatively weak and does not lead to sufficient reporter gene expression for noninvasive imaging, we specifically employed 2 signal amplification strategies, namely the Two Step Transcription Amplification (TSTA) strategy and the cytomegalovirus enhancer (CMVe) strategy, to maximize firefly luciferase reporter gene expression. Although both amplification strategies were capable of increasing pGB activity in activated primary murine splenocytes, only the level of bioluminescence activity achieved with the CMVe strategy was adequate for noninvasive imaging in mice. Using T cells transduced with a reporter vector containing the hybrid pGB-CMVe promoter, we were able to optically image T-cell effector function longitudinally in response to tumor antigens in living mice. This methodology has the potential to accelerate the study of adoptive immunotherapy in preclinical cancer models. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159636      PMCID: PMC3057959          DOI: 10.1158/0008-5472.CAN-10-1843

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Upstream elements bestow T-cell and haemopoietic progenitor-specific activity on the granzyme B promoter.

Authors:  B A Johnson; V A John; R Henschler; I N Hampson; C M Heyworth; C K Babichuk; R C Bleackley; T M Dexter; M A Cross
Journal:  Gene       Date:  1999-06-24       Impact factor: 3.688

2.  Modelling T-cell memory by genetic marking of memory T cells in vivo.

Authors:  J Jacob; D Baltimore
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

Review 3.  Transcriptional regulation of T lymphocyte development and function.

Authors:  C T Kuo; J M Leiden
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

4.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

5.  Visualization of a primary anti-tumor immune response by positron emission tomography.

Authors:  Chengyi J Shu; Shuling Guo; Young J Kim; Stephanie M Shelly; Amar Nijagal; Pritha Ray; Sanjiv S Gambhir; Caius G Radu; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

6.  Mutational analysis of the murine granzyme B gene promoter in primary T cells and a T cell clone.

Authors:  C K Babichuk; R C Bleackley
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

7.  'Green mice' as a source of ubiquitous green cells.

Authors:  M Okabe; M Ikawa; K Kominami; T Nakanishi; Y Nishimune
Journal:  FEBS Lett       Date:  1997-05-05       Impact factor: 4.124

8.  CD107a as a functional marker for the identification of natural killer cell activity.

Authors:  Galit Alter; Jessica M Malenfant; Marcus Altfeld
Journal:  J Immunol Methods       Date:  2004-11       Impact factor: 2.303

9.  Antigen distribution drives programmed antitumor CD8 cell migration and determines its efficiency.

Authors:  Alexandre Boissonnas; Christophe Combadiere; Elise Lavergne; Maud Maho; Catherine Blanc; Patrice Debré; Behazine Combadiere
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

10.  Transcription of granzyme A and B genes is differentially regulated during lymphoid ontogeny.

Authors:  K Ebnet; C N Levelt; T T Tran; K Eichmann; M M Simon
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  24 in total

1.  Transplantomics and biomarkers in organ transplantation: a report from the first international conference.

Authors:  Minnie M Sarwal; Jacqueline Benjamin; Atul J Butte; Mark M Davis; Kathryn Wood; Jeremy Chapman
Journal:  Transplantation       Date:  2011-02-27       Impact factor: 4.939

2.  Optimized Repopulation of Tendon Hydrogel: Synergistic Effects of Growth Factor Combinations and Adipose-Derived Stem Cells.

Authors:  Simon Farnebo; Lovisa Farnebo; Maxwell Kim; Colin Woon; Hung Pham; James Chang
Journal:  Hand (N Y)       Date:  2016-03-15

3.  Differential fates of biomolecules delivered to target cells via extracellular vesicles.

Authors:  Masamitsu Kanada; Michael H Bachmann; Jonathan W Hardy; Daniel Omar Frimannson; Laura Bronsart; Andrew Wang; Matthew D Sylvester; Tobi L Schmidt; Roger L Kaspar; Manish J Butte; A C Matin; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

Review 4.  Lymphocytes and the adventitial immune response in atherosclerosis.

Authors:  Kirsti A Campbell; Michael J Lipinski; Amanda C Doran; Marcus D Skaflen; Valentin Fuster; Coleen A McNamara
Journal:  Circ Res       Date:  2012-03-16       Impact factor: 17.367

Review 5.  Optical imaging for stem cell differentiation to neuronal lineage.

Authors:  Do Won Hwang; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2012-01-04

6.  Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma.

Authors:  Janice K Laramy; Minjee Kim; Shiv K Gupta; Karen E Parrish; Shuangling Zhang; Katrina K Bakken; Brett L Carlson; Ann C Mladek; Daniel J Ma; Jann N Sarkaria; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2017-08-28       Impact factor: 4.030

7.  Bioluminescence Imaging for Monitoring miR-200c Expression in Breast Cancer Cells and its Effects on Epithelial-Mesenchymal Transition Progress in Living Animals.

Authors:  Jing Liu; Jia-Xin Shen; Guo-Jun Zhang
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

8.  Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1.

Authors:  Lei Qian; Andrew M Bradford; Peter H Cooke; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2016-02-12       Impact factor: 2.137

9.  Mechanoresponsive stem cells to target cancer metastases through biophysical cues.

Authors:  Linan Liu; Shirley X Zhang; Wenbin Liao; Henry P Farhoodi; Chi W Wong; Claire C Chen; Aude I Ségaliny; Jenu V Chacko; Lily P Nguyen; Mengrou Lu; George Polovin; Egest J Pone; Timothy L Downing; Devon A Lawson; Michelle A Digman; Weian Zhao
Journal:  Sci Transl Med       Date:  2017-07-26       Impact factor: 17.956

Review 10.  Bioluminescence imaging: progress and applications.

Authors:  Christian E Badr; Bakhos A Tannous
Journal:  Trends Biotechnol       Date:  2011-07-23       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.